Potent Anti-Mesothelioma Activity by the Novel Naftopidil Analogue HUHS1015; Preclinical Evidence for Treatment

被引：0

作者：

Kuribayashi, Kozo ^{[1
]}

Ieki, Ryuji ^{[1
]}

Otsuki, Taiichiro ^{[1
]}

Gotoh, Akinobu ^{[2
]}

Tanaka, Akito ^{[3
]}

Nishizaki, Tomoyuki ^{[4
]}

Nakano, Takashi ^{[1
]}

机构：

[1] Hyogo Coll Med, Dept Internal Med, Div Resp Med, Nishinomiya, Hyogo 6638501, Japan

[2] Hyogo Coll Med, Inst Adv Med Sci, Lab Cell & Gene Therapy, Nishinomiya, Hyogo 6638501, Japan

[3] Hyogo Univ Hlth Sci, Adv Med Res Ctr, Lab Chem Biol, Kobe, Hyogo, Japan

[4] Hyogo Coll Med, Dept Physiol, Nishinomiya, Hyogo 6638501, Japan

来源：

JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期

关键词：

Naftopidil; anticancer drug; apoptosis; Malignant pleural mesotelioma (MPM);

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MINI25.03

引用

页码：S352 / S352

页数：1

共 45 条

[41] Hexabody-CD38, a Novel CD38 Antibody with a Hexamerization Enhancing Mutation, Demonstrates Enhanced Complement-Dependent Cytotoxicity and Shows Potent Anti-Tumor Activity in Preclinical Models of Hematological Malignancies
De Goeij, Bart E. C. G.
Janmaat, Maarten L.
Andringa, Grietje
Kil, Laurens
Van Kessel, Berris
Frerichs, Kristine A.
Lingnau, Andreas
Freidig, Andreas
Mutis, Tuna
Sasser, A. Kate
Breij, Esther C. W.
Van de Donk, Niels W. C. J.
Ahmadi, Tahamtan
Satijn, David
BLOOD, 2019, 134
[42] PRT2527, a Novel Highly Selective Cyclin-Dependent Kinase 9 (CDK9) Inhibitor, Has Potent Anti-Leukemic Activity in Preclinical Primary Models of Human B-ALL, T-ALL, and CLL
Bhagwat, Neha
Ruggeri, Bruce
Zhang, Yang
Mosesson, Yaron
Killick-Cole, Clare
Jagannathan, Veena
Scherle, Peggy
BLOOD, 2022, 140
[43] Preclinical Pharmacokinetics and Acute Toxicity in Rats of 5-{[(2E)-3-Bromo-3-carboxyprop-2-enoyl]amino}-2-hydroxybenzoic Acid: A Novel 5-Aminosalicylic Acid Derivative with Potent Anti-Inflammatory Activity
Gutierrez-Sanchez, Mara
Romero-Castro, Aurelio
Correa-Basurto, Jose
Rosales-Hernandez, Martha Cecilia
Padilla-Martinez, Itzia Irene
Mendieta-Wejebe, Jessica Elena
MOLECULES, 2021, 26 (22):
[44] An efficient, short synthesis and potent anti-hepatitis B viral activity of a novel ring-expanded purine nucleoside analogue containing a 5:7-fused, planar, aromatic, imidazo [4,5-E][1,3]diazepine ring system
Chen, HM
Sood, R
Hosmane, RS
NUCLEOSIDES & NUCLEOTIDES, 1999, 18 (03): : 331 - 335
[45] LX-101, a novel, clinical stage, payload-bearing targeted therapy directed to the insulin-like growth factor receptor (IGF-1R), demonstrates potent preclinical anti-tumor activity against multiple cancer types with well-established ties to the IGF-1/IGF-1R pathway
Hoberman, Matt
Dudek, Arkadiusz Z.
CANCER RESEARCH, 2024, 84 (06)

← 1 2 3 4 5 →